Clonitazene

This classification denotes an opioid receptor agonist with the molecular formula C20H23ClN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S90R21A2V2, chemically known as 1h-benzeimidazole-1-ethanamine, 2-((4-chlorophenyl)methyl)-n,n-diethyl-5-nitro- but generally known as clonitazene, which bears US NIH Compound Identifier 62528. European Medicines Agency schedules Clonitazene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06731MIG. The term CLONITAZENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). CLONITAZENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clonitazene under HS 29339990 and SITC 51577. As of Q4 2014, CLONITAZENE remains the US FDA Preferred Term for this commodity. Clonitazene bears US NLM identifiers UMLS ID C2699374 and NCI Concept Code C77283. SMILES: CLC1CCC(CC2N(CCN(CC)CC)C3C(N2)CC([N](=O)O)CC3)CC1.